Gilead Sciences | 普通株資本



Ordinary Share Capital 変化する 日付
AbbVie USD 18M 0 2024-12
Agios Pharmaceuticals USD 58.04M 57.96M 2025-06
ALKERMES USD 165.05M 163.25M 2025-06
Alnylam Pharmaceuticals USD 130.98M 129.67M 2025-06
Amgen USD 33.58B 45M 2025-03
Biogen USD 146.6M 146.5M 2025-06
BioMarin Pharmaceutical USD 192K 1000 2025-03
Bristol-Myers Squibb USD 2.04B 1.74B 2025-06
Eli Lilly USD 592.6M 200K 2025-03
Gilead Sciences USD 1000K 0 2024-12
GlaxoSmithKline GBP 4.15B 2.8B 2025-06
Glaxosmithkline GBP 1.35B 0 2024-12
Incyte USD 194.12M 193.93M 2025-06
J&J USD 3.12B 0 2025-03
Merck USD 1.79B 0 2025-03
Moderna USD 389M 388.96M 2025-06
Neurocrine Biosciences USD 99M 0 2025-06
Novartis USD 793M 0 2024-12
Pfizer USD 481M 1000K 2025-03
PTC Therapeutics USD 78K 1000 2025-03
Regeneron Pharmaceuticals USD 106.4M 106.4M 2025-06
Sanofi 1.22B 36.5M 2025-06
Sarepta Therapeutics USD 10K 0 2025-03
United Therapeutics USD 45.22M 44.42M 2025-06
Vertex Pharmaceuticals USD 256.3M 253.7M 2025-06


Gilead Sciences 普通株資本 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Aug 2025.